The Effect of Peri-Operative Adjunctive Probiotics on Immunological Markers in Cases of Prosthetic Joint Infection of the Hip and Knee
Part of paid clinical trials in New York, New York.
- Sponsor
- NYU Langone Health
- Study ID
- NCT06919913
- Status
- Recruiting
Conditions
- Prosthetic-joint Infection
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 90 Years
- Healthy Volunteers
- Not accepted
Interventions
- Culturelle Digestive Daily Probiotic Capsule — DIETARY_SUPPLEMENTEach capsule contains 10 billion colony-forming units (CFU) of Lactobacillus rhamnosus GG. Subjects will self-administer 1 oral capsule daily for 6 weeks post operatively.
Study Details
The purpose of this study is to determine whether probiotics in addition to standard of care (SOC) can improve immunological markers following treatment for prosthetic joint infection (PJI). The study aims to determine whether probiotics in addition to SOC decrease immunological markers following treatment for PJI, improve medical and surgical complications and mortality in patients with PJI, and lead to improved gastrointestinal (GI)-specific patient reported outcomes measures (PROMs) in patients with PJI.
Key Dates
- Start date
- Jul 12, 2025
- Status verified
- Mar 2026
- Primary completion
- Jan 1, 2027
- Completion
- Jan 1, 2027
Study Design
- Enrollment
- 152 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- PREVENTION
Arms
- Experimental: Probiotic supplementation + Standard of carePatients will receive their first dose of the probiotic within 48 hours of starting post-operative antibiotic treatment. The probiotic is continued for the initial 6 weeks of antibiotic treatment in addition to standard of care (SOC).
- No Intervention: Standard of care alonePatients do not receive any additional treatment and undergo SOC treatment.
Primary Outcome Measure
Change in erythrocyte sedimentation rate (ESR) [ Time Frame: Baseline, 6 weeks post-antibiotic therapy ]
Central Contacts
- Ran Schwarzkopf, MD212-598-6000
- Daniel Waren212-598-6245
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| NYU Langone Health | New York | New York | 10016 | - |
Find similar trials in New York, NY
By research site
Related Studies
- Probiotics in the Prevention of Recurrent Prosthetic Joint Infection of the Hip and KneePHASE4 · Enrolling By Invitation · Boston Medical Center · Boston, Massachusetts
- Real-component vs All-cement Articulating Spacers for Periprosthetic Knee InfectionRecruiting · Northwestern University · Chicago, Illinois
- Evaluation of PLG0206 in Prevention of Recurrent Infection in Patients Undergoing Debridement, Antibiotics, and Implant Retention (DAIR) for Treatment of a Periprosthetic Joint Infection (PJI) Following Knee ArthroplastyPHASE2/PHASE3 · Recruiting · Peptilogics · Sarasota, Florida
- Methylene Blue in Total Knee Arthroplasty (TKA)PHASE1 · Recruiting · University of Miami · Miami, Florida